BioSpace News Archive

Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, granted equity awards on January 31, 2020 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2014 Employment Commencement Incentive Plan, as a material inducement to employment to nineteen individuals hired by Sarepta in January 2020.

Findings on the tests’ performance published today in AACC’s Clinical Chemistry Journal [31-January-2020] WASHINGTON , Jan. 31, 2020 /PRNewswire/ -- Breaking research in AACC’s Clinical Chemistry journal shows that two new tests accurately diagnose coronavirus infection in about 1 hour. These tests could play a critical role in halting this deadly outbreak by enab

Spero Therapeutics, Inc. (Nasdaq: SPRO), today announced that on January 31, 2020 the Compensation Committee of Spero’s Board of Directors granted non-qualified stock option awards to purchase an aggregate of 6,000 shares of its common stock to two new employees under the Spero Therapeutics, Inc.

SGI-DNA, creators of the BioXp™ 3200 System and Gibson Assembly® Reagents, has launched Vmax™ X2 Competent Cells, designed to generate two to four times more soluble protein in half of the time of current methods reliant on E. coli.

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, today announced that company management will present at the BIO CEO and Investor Conference on Monday, February 10, 2020 at 9:30 a.m. ET in New York, NY.

Oklahoma-based dental specialist joins leadership of the premier organization for prosthodontics

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has won the prestigious customer satisfaction award ‘Best in KLAS’ for the seventh consecutive year in the US.

Navigant, a Guidehouse company, has been recognized as Best in KLAS for its services and software solutions in a pair of categories. According to the 2020 Best in KLAS: Software & Services report, Navigant is ranked as the top performer in both the Strategy, Growth, and Consolidation Consulting category and in the Value-Based Care Consulting category.

SpendEdge has been monitoring the global clinical research services market and the market is poised to experience spend growth of more than USD 14 billion between 2019-2024 at a CAGR of over 6% during the forecast period

Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), today announced that the Institut für das Entgeltsystem im Krankenhaus (“InEK”), (the German Institute for the Hospital Remuneration System), has awarded the Neovasc Reducer™ (“Reducer”), a CE-Marked medical device for the treatment of refractory angina, NUB Status 1 designation once again for 2020.